Photo credit: commons.wikimedia.org

“I buy on the assumption that they could close the market the next day and not reopen it for five years.”

— Warren Buffett

A critical pearl of wisdom from Warren Buffett teaches us that with any potential stock investment we may make, as soon as our buy order is filled we will have a choice: to remain a co-owner of that company for the long haul, or to react to the inevitable short-term ups and downs that the stock market is famous for (sometimes sharp ups and downs).

The reality of this choice forces us to challenge our confidence in any given company we might invest into, and keep our eyes on the long-term time horizon. The market may go up and down the interim, but over a five year holding period, will the investment succeed?

Back in 2016, investors may have been asking themselves that very question about Charles River Laboratories International Inc. (NYSE: CRL). Let’s examine what would have happened over a five year holding period, had you invested in CRL shares back in 2016 and held on.

Start date: 10/05/2016
$10,000

10/05/2016
$48,033

10/04/2021
End date: 10/04/2021
Start price/share: $82.97
End price/share: $398.46
Starting shares: 120.53
Ending shares: 120.53
Dividends reinvested/share: $0.00
Total return: 380.25%
Average annual return: 36.87%
Starting investment: $10,000.00
Ending investment: $48,033.18

As shown above, the five year investment result worked out exceptionally well, with an annualized rate of return of 36.87%. This would have turned a $10K investment made 5 years ago into $48,033.18 today (as of 10/04/2021). On a total return basis, that’s a result of 380.25% (something to think about: how might CRL shares perform over the next 5 years?). [These numbers were computed with the Dividend Channel DRIP Returns Calculator.]

One more piece of investment wisdom to leave you with:
“In the long run, it’s not just how much money you make that will determine your future prosperity. It’s how much of that money you put to work by saving it and investing it.” — Peter Lynch